ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

GENSCI136

A development code. Also written as “GenSci136 for injection” and “GenSci136”.

Its studies are mostly in Autoimmune Diseases, led by Changchun GeneScience Pharmaceutical.

Furthest: phase 2, since Oct 27, 20262 company-led studies, 2 open or runningNext primary completion: Feb 7, 2027 (phase 1)

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Changchun GeneScience Pharmaceutical22 open or runningphase 2since Oct 27, 2026Jan 7, 2026Feb 7, 2027phase 1 · NCT07366866

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jan 7, 2026First study: phase 1 study in Autoimmune DiseasesFirst studyNCT07366866 · 56 planned · China
  2. Oct 27, 2026Phase 2 study in Patients With MG (gMG and oMG)Phase 2 reachedNCT07936084 · 72 planned · China

Ahead

  1. Feb 7, 2027Primary completion: phase 1 study in Autoimmune DiseasesNCT07366866
  2. Dec 2028Primary completion: phase 2 study in Patients With MG (gMG and oMG)NCT07936084

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 2 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07936084Patients With MG (gMG and oMG) · China2Not yet recruitingDec 202872
NCT07366866Autoimmune Diseases · China1RecruitingFeb 7, 202756

How it is read

Names in the registry

  • “GenSci136 for injection”, 1 entry
  • “GenSci136”, 1 entry

Codes read as this program: GENSCI136.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.